Publications

Show Filters

Searches all publications.

Search Term

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-02-25
    E.g., 2018-02-25

Articles

254624 items
12:00 AM, Feb 28, 1994  |  BC Week In Review | Clinical News  |  Clinical Results

Atrigel polymerizing gel data

ATRX will drop development of its plant-derived anti-microbial, sanguinarine, and instead will use doxycycline in its drug delivery gel. A clarifying study in 180 patients presented to the FDA last week showed that sanguinarine...
12:00 AM, Feb 28, 1994  |  BC Week In Review | Clinical News  |  Regulatory

Cholestech regulatory update

CTEC (Hayward, Calif.) received notice of allowance for a U.S. patent covering its technology to measure lipoprotein (a). Lp(a) is a cholesterol carrier that has been shown to be an independent risk factor for coronary...
12:00 AM, Feb 28, 1994  |  BioCentury | Strategy

Numbers didn't add up for Maitec

Numbers didn't add up for Maitec Knowing when to quit is as important as knowing when to forge ahead. The Liposome Co. Inc., which has a full plate of development projects, last week said it...
12:00 AM, Feb 28, 1994  |  BC Week In Review | Company News  |  Other News

Isis other research news

ISIP (Carlsbad, Calif.) announced an anti-AIDS candidate discovered through the same proprietary, combinatorial selection strategy that has produced antisense agents. In the Proceedings of the National Academy of Sciences, the company described the action...
12:00 AM, Feb 28, 1994  |  BC Week In Review | Company News  |  Other News

Biogen other research news

Gelsolin, a protein from human plasma that severs actin fibers, can thin the mucus of cystic fibrosis (CF) patients. Harvard researchers showed that the mucus contains filamentous actin, and that gelsolin decreased the viscosity...
12:00 AM, Feb 28, 1994  |  BC Week In Review | Company News  |  Deals

Quadra Logic Technologies Inc. deal

QLTIF (Vancouver) will collaborate with Laserscope to develop, manufacture and distribute photodynamic therapy (PDT) devices. The companies believe the collaboration can substantially reduce the cost of performing PDT. QLTIF said Laserscope's PDT light source...
12:00 AM, Feb 28, 1994  |  BC Week In Review | Company News  |  Other News

DNA Plant Technology Corp. news

The Cinnaminson, N.J.-based company is relocating its corporate headquarters to Oakland, Calif. The move, which will occur by July 1, will save $2 million a year, a spokesperson estimated. DNAP chose Oakland because of...
12:00 AM, Feb 28, 1994  |  BioCentury | Analyst Picks & Changes

Analyst picks & changes

VimRx Pharmaceuticals Inc. (VMRX) Gary Davis of Jesup & Lamont began coverage with a "buy" recommendation and an 18-month price target of $4. VMRX's lead product, the antiviral VIMRxyn hypericin, will begin Phase I/II trials...
12:00 AM, Feb 28, 1994  |  BioCentury | Analyst Picks & Changes

Analyst picks & changes

Embrex Inc. (EMBX) Foley Mufson Howe analyst Sue Slezak reiterated a puchase recommendation, saying the stock, trading at a 52-week low, is undervalued. The stock price doesn't reflect a strengthened cash position or progress EMBX...
12:00 AM, Feb 28, 1994  |  BioCentury | Politics, Policy & Law

Preposterous

According to one of those unattributed reports that regularly emanate from Washington, Clinton health care mastermind Ira Magaziner earlier this month called the Biotechnology Industry Organization to task for the industry's relentless campaign against the...

Pages